| Min Pa: | Min Pa(max): | Activity's type: |
| Ext | Pa | Pi | Pmax | Activity | Other Results | ID Pa_max |
|---|---|---|---|---|---|---|
| 0.453 | 0.014 | 0.453 | Peroxidase inhibitor | 0.21 0.056 CID_149047 | ||
| 0.368 | 0.012 | 0.368 | Tyrosine 3 hydroxylase inhibitor | 0.301 0.033 CID_149047 | ||
| 0.402 | 0.11 | 0.402 | Caspase 9 stimulant | 0.398 0.112 CID_149047 | ||
| 0.382 | 0.118 | 0.382 | Ca2+/calmodulin-dependent protein kinase kinase A inhibitor | 0.382 0.117 CID_149047 | ||
| 0.248 | 0.016 | 0.248 | 5-Lipoxygenase inhibitor | |||
| 0.243 | 0.017 | 0.243 | Alkylator | 0.157 0.043 CID_149047 | ||
| 0.226 | 0.008 | 0.226 | MAP3K9 inhibitor | 0.205 0.013 CID_149047 | ||
| 0.271 | 0.065 | 0.271 | Tumour necrosis factor alpha release inhibitor | 0.232 0.084 CID_149047 | ||
| 0.286 | 0.083 | 0.286 | Immunostimulant | 0.164 0.143 CID_149047 | ||
| 0.309 | 0.11 | 0.358 | GABA C receptor rho-3 antagonist | 0.358 0.081 CID_149047 | CID_149047 | |
| 0.212 | 0.019 | 0.212 | MAP kinase 3 inhibitor | |||
| 0.228 | 0.041 | 0.228 | Lipocortins synthesis antagonist | 0.228 0.041 CID_149047 | ||
| 0.209 | 0.029 | 0.209 | Death-associated protein kinase 2 inhibitor | |||
| 0.203 | 0.035 | 0.203 | ATPase inhibitor | 0.148 0.106 CID_149047 | ||
| 0.182 | 0.017 | 0.182 | GABA C receptor antagonist | 0.135 0.039 CID_149047 | ||
| 0.311 | 0.153 | 0.363 | 5 Hydroxytryptamine release inhibitor | 0.363 0.105 CID_149047 | CID_149047 | |
| 0.231 | 0.088 | 0.231 | Superoxide dismutase inhibitor | 0.218 0.099 CID_149047 | ||
| 0.194 | 0.053 | 0.194 | Heat shock protein 90 alpha antagonist | |||
| 0.265 | 0.13 | 0.265 | Calcium channel activator | 0.249 0.149 CID_149047 | ||
| 0.173 | 0.054 | 0.173 | NOS3 expression enhancer | 0.13 0.097 CID_149047 | ||
| 0.152 | 0.033 | 0.154 | GABA C receptor agonist | 0.154 0.032 CID_149047 | CID_149047 | |
| 0.135 | 0.025 | 0.135 | Triose-phosphate isomerase inhibitor | 0.113 0.037 CID_149047 | ||
| 0.152 | 0.044 | 0.152 | Adenylate cyclase inhibitor | 0.105 0.08 CID_149047 | ||
| 0.112 | 0.007 | 0.112 | Histone deacetylase class II inhibitor | |||
| 0.156 | 0.052 | 0.172 | Alpha-N-acetylglucosaminidase inhibitor | 0.172 0.044 CID_149047 | CID_149047 | |
| 0.186 | 0.083 | 0.235 | Anesthetic general | 0.235 0.057 CID_149047 | CID_149047 | |
| 0.137 | 0.034 | 0.137 | Carbonic anhydrase III inhibitor | |||
| 0.111 | 0.009 | 0.111 | Dopamine D2 agonist | |||
| 0.151 | 0.051 | 0.151 | MAP kinase kinase inhibitor | 0.107 0.087 CID_149047 | ||
| 0.215 | 0.114 | 0.215 | 5 Hydroxytryptamine 1E antagonist | |||
| 0.108 | 0.009 | 0.108 | Histone deacetylase 2 inhibitor | |||
| 0.211 | 0.113 | 0.219 | 5 Hydroxytryptamine release stimulant | 0.219 0.107 CID_149047 | CID_149047 | |
| 0.112 | 0.014 | 0.112 | Histone deacetylase inhibitor | |||
| 0.222 | 0.127 | 0.222 | Insulysin inhibitor | |||
| 0.105 | 0.011 | 0.105 | AMPA receptor antagonist | 0.042 0.041 CID_149047 | ||
| 0.146 | 0.053 | 0.155 | Ca2+-transporting ATPase inhibitor | 0.155 0.032 CID_149047 | CID_149047 | |
| 0.102 | 0.009 | 0.102 | Histone deacetylase 5 inhibitor | |||
| 0.217 | 0.124 | 0.217 | Lipoxygenase inhibitor | |||
| 0.168 | 0.076 | 0.168 | Phospholipase C inhibitor | 0.145 0.117 CID_149047 | ||
| 0.112 | 0.021 | 0.112 | Phenylalanine 4-hydroxylase inhibitor | 0.06 0.058 CID_149047 | ||
| 0.179 | 0.089 | 0.179 | Focal adhesion kinase 2 inhibitor | 0.171 0.099 CID_149047 | ||
| 0.097 | 0.008 | 0.097 | Histone deacetylase 1 inhibitor | |||
| 0.123 | 0.039 | 0.123 | Sphingomyelinase inhibitor | |||
| 0.118 | 0.035 | 0.119 | Estrogen receptor beta antagonist | 0.119 0.033 CID_149047 | CID_149047 | |
| 0.212 | 0.13 | 0.239 | 5 Hydroxytryptamine uptake stimulant | 0.239 0.093 CID_149047 | CID_149047 | |
| 0.166 | 0.085 | 0.174 | Succinate dehydrogenase inhibitor | 0.174 0.076 CID_149047 | CID_149047 | |
| 0.147 | 0.068 | 0.148 | Adenylate cyclase stimulant | 0.148 0.066 CID_149047 | CID_149047 | |
| 0.12 | 0.043 | 0.12 | UDP-glucose 4-epimerase inhibitor | 0.09 0.073 CID_149047 | ||
| 0.084 | 0.008 | 0.084 | Histone deacetylase class IIb inhibitor | |||
| 0.104 | 0.029 | 0.104 | Glycine receptor antagonist | 0.087 0.047 CID_149047 | ||
| 0.083 | 0.008 | 0.083 | Histone deacetylase 6 inhibitor | |||
| 0.124 | 0.05 | 0.124 | Aminopeptidase B inhibitor | 0.089 0.073 CID_149047 | ||
| 0.087 | 0.014 | 0.087 | Potassium channel intermediate-conductance Ca-activated blocker | 0.056 0.051 CID_149047 | ||
| 0.112 | 0.04 | 0.112 | NMDA receptor antagonist | |||
| 0.1 | 0.03 | 0.1 | Glutamate decarboxylase inhibitor | 0.096 0.032 CID_149047 | ||
| 0.166 | 0.098 | 0.229 | Non-steroidal antiinflammatory agent | 0.229 0.052 CID_149047 | CID_149047 | |
| 0.119 | 0.051 | 0.119 | Platelet activating factor beta antagonist | |||
| 0.123 | 0.055 | 0.123 | Transcription factor STAT6 inhibitor | |||
| 0.089 | 0.023 | 0.089 | S-adenosyl-L-methionine decarboxylase inhibitor | 0.068 0.065 CID_149047 | ||
| 0.133 | 0.067 | 0.187 | Acetylcholinesterase inhibitor | 0.187 0.037 CID_149047 | CID_149047 | |
| 0.206 | 0.14 | 0.217 | Gastrin inhibitor | 0.217 0.123 CID_149047 | CID_149047 | |
| 0.075 | 0.01 | 0.075 | Histone deacetylase class IIa inhibitor | |||
| 0.144 | 0.081 | 0.144 | Heat shock protein 90 antagonist | |||
| 0.169 | 0.111 | 0.197 | Neurotrophic factor enhancer | 0.197 0.079 CID_149047 | CID_149047 | |
| 0.118 | 0.059 | 0.125 | Estrogen antagonist | 0.125 0.047 CID_149047 | CID_149047 | |
| 0.092 | 0.034 | 0.092 | Estrogen receptor alpha antagonist | 0.085 0.042 CID_149047 | ||
| 0.069 | 0.012 | 0.069 | Immunoglobulin Fc receptor antagonist | |||
| 0.081 | 0.024 | 0.081 | Aminopeptidase microsomal inhibitor | |||
| 0.107 | 0.053 | 0.107 | Creatine kinase inhibitor | 0.088 0.074 CID_149047 | ||
| 0.134 | 0.08 | 0.134 | Protein kinase stimulant | |||
| 0.11 | 0.056 | 0.11 | Urease inhibitor | |||
| 0.174 | 0.122 | 0.174 | 5 Hydroxytryptamine 3E antagonist | |||
| 0.183 | 0.131 | 0.183 | DNA damaging | 0.171 0.144 CID_149047 | ||
| 0.108 | 0.056 | 0.109 | Adenylate kinase inhibitor | 0.109 0.055 CID_149047 | CID_149047 | |
| 0.201 | 0.15 | 0.201 | 12-Lipoxygenase inhibitor | |||
| 0.111 | 0.061 | 0.13 | Ferrochelatase inhibitor | 0.13 0.048 CID_149047 | CID_149047 | |
| 0.165 | 0.116 | 0.165 | Glyceraldehyde-3-phosphate dehydrogenase inhibitor | 0.155 0.137 CID_149047 | ||
| 0.089 | 0.039 | 0.141 | Keratolytic | 0.141 0.016 CID_149047 | CID_149047 | |
| 0.06 | 0.011 | 0.06 | Histone deacetylase 11 inhibitor | |||
| 0.06 | 0.011 | 0.06 | Histone deacetylase class IV inhibitor | |||
| 0.063 | 0.015 | 0.063 | Kainate receptor antagonist | |||
| 0.062 | 0.016 | 0.062 | Adenylate cyclase 1 inhibitor | 0.045 0.033 CID_149047 | ||
| 0.056 | 0.01 | 0.056 | Histone deacetylase 10 inhibitor | |||
| 0.143 | 0.097 | 0.175 | Arachidonic acid antagonist | 0.175 0.059 CID_149047 | CID_149047 | |
| 0.058 | 0.013 | 0.058 | Dopamine D5 agonist | 0.05 0.018 CID_149047 | ||
| 0.046 | 0.003 | 0.046 | Human herpes virus 5 capsid protein P40 inhibitor | 0.027 0.004 CID_149047 | ||
| 0.054 | 0.011 | 0.054 | Histone deacetylase 4 inhibitor | |||
| 0.071 | 0.029 | 0.071 | 5 Hydroxytryptamine 6 antagonist | |||
| 0.08 | 0.038 | 0.091 | Glycine receptor agonist | 0.091 0.028 CID_149047 | CID_149047 | |
| 0.053 | 0.012 | 0.053 | Phenylethanolamine N methyltransferase inhibitor | 0.04 0.028 CID_149047 | ||
| 0.05 | 0.01 | 0.05 | ADAM10 endopeptidase inhibitor | |||
| 0.053 | 0.014 | 0.053 | Acid-sensing ion channel blocker | 0.052 0.014 CID_149047 | ||
| 0.062 | 0.023 | 0.062 | Aminopeptidase N inhibitor | |||
| 0.1 | 0.062 | 0.1 | GABA C receptor rho-1 antagonist | 0.098 0.065 CID_149047 | ||
| 0.058 | 0.02 | 0.058 | Glucose-6-phosphate isomerase inhibitor | |||
| 0.076 | 0.039 | 0.076 | Dopamine agonist | |||
| 0.133 | 0.099 | 0.148 | GABA C receptor rho-2 antagonist | 0.148 0.077 CID_149047 | CID_149047 | |
| 0.056 | 0.024 | 0.056 | Adenosine deaminase inhibitor | |||
| 0.098 | 0.066 | 0.116 | Anabolic | 0.116 0.043 CID_149047 | CID_149047 | |
| 0.06 | 0.029 | 0.06 | Dihydroorotate oxidase inhibitor | |||
| 0.042 | 0.011 | 0.042 | Histone deacetylase 3 inhibitor | |||
| 0.053 | 0.024 | 0.053 | Thymidylate synthase inhibitor | |||
| 0.091 | 0.065 | 0.102 | Prolactin inhibitor | 0.102 0.053 CID_149047 | CID_149047 | |
| 0.1 | 0.075 | 0.106 | DOPA decarboxylase inhibitor | 0.106 0.064 CID_149047 | CID_149047 | |
| 0.045 | 0.02 | 0.045 | Alpha 1d adrenoreceptor agonist | |||
| 0.122 | 0.098 | 0.122 | Mannose-6-phosphate isomerase inhibitor | |||
| 0.067 | 0.046 | 0.077 | Glutamate (mGluR6) antagonist | 0.077 0.028 CID_149047 | CID_149047 | |
| 0.051 | 0.03 | 0.051 | Collagenase inhibitor | |||
| 0.111 | 0.089 | 0.175 | Cyclooxygenase 1 inhibitor | 0.175 0.045 CID_149047 | CID_149047 | |
| 0.053 | 0.034 | 0.053 | Aconitate hydratase inhibitor | 0.048 0.042 CID_149047 | ||
| 0.102 | 0.084 | 0.102 | TRPA1 agonist | 0.098 0.092 CID_149047 | ||
| 0.083 | 0.066 | 0.089 | Granulocyte macrophage colony stimulating factor agonist | 0.089 0.054 CID_149047 | CID_149047 | |
| 0.101 | 0.086 | 0.106 | Photosensitizer | 0.106 0.077 CID_149047 | CID_149047 | |
| 0.077 | 0.061 | 0.077 | Carbonic anhydrase VI inhibitor | |||
| 0.023 | 0.007 | 0.023 | Ileal bile acid transport inhibitor | |||
| 0.044 | 0.029 | 0.044 | Glutamate (mGluR4) antagonist | |||
| 0.152 | 0.137 | 0.152 | Aldehyde oxidase inhibitor | |||
| 0.059 | 0.047 | 0.059 | NMDA receptor glycine site agonist | |||
| 0.071 | 0.06 | 0.075 | GABA aminotransferase inhibitor | 0.075 0.053 CID_149047 | CID_149047 | |
| 0.036 | 0.026 | 0.036 | Histone deacetylase 7 inhibitor | |||
| 0.051 | 0.041 | 0.051 | 3(or 17)beta-hydroxysteroid dehydrogenase inhibitor | |||
| 0.034 | 0.026 | 0.039 | Retinoid X alpha receptor agonist | 0.039 0.02 CID_149047 | CID_149047 | |
| 0.042 | 0.034 | 0.042 | Glutamate (mGluR group III) antagonist | |||
| 0.09 | 0.082 | 0.09 | Mediator release inhibitor | |||
| 0.051 | 0.044 | 0.082 | Alcohol oxidase inhibitor | 0.082 0.023 CID_149047 | CID_149047 | |
| 0.082 | 0.076 | 0.082 | HIV-1 integrase (Overall Integration) inhibitor | |||
| 0.039 | 0.033 | 0.039 | Dopamine D5 antagonist | |||
| 0.04 | 0.034 | 0.04 | Macrophage elastase inhibitor | |||
| 0.054 | 0.048 | 0.054 | Botulinum neurotoxin type A inhibitor | |||
| 0.02 | 0.015 | 0.02 | Retinoid X beta receptor antagonist | 0.02 0.016 CID_149047 | ||
| 0.079 | 0.076 | 0.079 | NADH dehydrogenase inhibitor | |||
| 0.023 | 0.02 | 0.024 | Glutamate (mGluR1) agonist | 0.024 0.018 CID_149047 | CID_149047 | |
| 0.031 | 0.028 | 0.031 | Retinoid X receptor agonist | 0.03 0.029 CID_149047 | ||
| 0.07 | 0.068 | 0.07 | GABA B receptor agonist | |||
| 0.027 | 0.024 | 0.027 | Purinergic P2Y15 antagonist | |||
| 0.034 | 0.034 | 0.035 | Retinoid X receptor antagonist | 0.035 0.033 CID_149047 | CID_149047 | |
| 0.031 | 0.031 | 0.031 | Retinoid X alpha receptor antagonist | 0.031 0.03 CID_149047 | CID_149047 | |
| 0.133 | 0.133 | 0.208 | Pyruvate kinase inhibitor | 0.208 0.077 CID_149047 | CID_149047 | |
| 0.167 | 0.172 | 0.178 | DNA synthesis inhibitor | 0.178 0.156 CID_149047 | CID_149047 | |
| 0.06 | 0.067 | 0.067 | Porphobilinogen synthase inhibitor | 0.067 0.059 CID_149047 | CID_149047 | |
| 0.035 | 0.049 | 0.041 | Kainate receptor agonist | 0.041 0.028 CID_149047 | CID_149047 | |
| 0.057 | 0.073 | 0.065 | Glutamate (mGluR7) antagonist | 0.065 0.053 CID_149047 | CID_149047 | |
| 0.072 | 0.099 | 0.081 | Estrogen-related receptor beta agonist | 0.081 0.064 CID_149047 | CID_149047 | |
| 0.185 | 0.222 | 0.215 | Histamine release inhibitor | 0.215 0.186 CID_149047 | CID_149047 | |
| 0.153 | 0.191 | 0.167 | RNA-directed DNA polymerase inhibitor | 0.167 0.158 CID_149047 | CID_149047 | |
| 0.098 | 0.142 | 0.206 | Cholinergic | 0.206 0.044 CID_149047 | CID_149047 | |
| 0.148 | 0.22 | 0.167 | Nitric-oxide synthase stimulant | 0.167 0.16 CID_149047 | CID_149047 | |
| 0.054 | 0.131 | 0.374 | Topoisomerase I inhibitor | 0.374 0.006 CID_149047 | CID_149047 | |
| 0.075 | 0.157 | 0.14 | Cyclooxygenase 3 inhibitor | 0.14 0.057 CID_149047 | CID_149047 | |
| 0.067 | 0.19 | 0.112 | Cyclooxygenase inhibitor | 0.112 0.109 CID_149047 | CID_149047 | |
| 0.128 | 0.284 | 0.197 | Vasodilator, coronary | 0.197 0.184 CID_149047 | CID_149047 | |
| 0.064 | 0.236 | 0.171 | Aryl hydrocarbon receptor agonist | 0.171 0.12 CID_149047 | CID_149047 | |
| 0.07 | 0.299 | 0.161 | Growth hormone agonist | 0.161 0.079 CID_149047 | CID_149047 | |
| 0.011 | 0.255 | 0.103 | Aldose reductase inhibitor | 0.103 0.017 CID_149047 | CID_149047 | |
| 0.018 | 0.327 | 0.181 | Butyrylcholinesterase inhibitor | 0.181 0.025 CID_149047 | CID_149047 | |
| 0.069 | 0.616 | 0.39 | Antiinflammatory | 0.39 0.145 CID_149047 | CID_149047 | |
| 0.027 | 0.614 | 0.215 | Aurora-C kinase inhibitor | 0.215 0.016 CID_149047 | CID_149047 | Ext | Pa | Pi | Pmax | Activity | Other Results | ID Pa_max |